1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Xu, Y. Wu, J. Pei, J. Shi, Y. Ji, Y. Tong, Q. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 39 13669 13675 10.1021/bi000860s 11076505 Solution structure of BmP02, a new potassium channel blocker from the venom of the Chinese scorpion Buthus martensi Karsch. 2000 10.2210/pdb1du9/pdb pdb_00001du9 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2959.424 BMP02 NEUROTOXIN 1 nat polymer no no VGCEECPMHCKGKNAKPTCDDGVCNCNV VGCEECPMHCKGKNAKPTCDDGVCNCNV A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n Chinese scorpion Mesobuthus sample 34649 Mesobuthus martensii VENOM database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2000-02-04 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession RCSB Y RCSB 2000-01-17 REL REL This structure was determined using standard 2D homonuclear techniques. structures with the least restraint violations 50 25 2D NOESY DQF-COSY TOCSY 2D NOESY DQF-COSY TOCSY 0 4.0 1 atm 300 K simulated annealing and ENERGY MINIMIZATION 1 minimized average structure 3mM BmP02; 90% H2O, 10% D2O 90% H2O/10% D2O 3mM BmP02; 100% D2O 100% D2O BRUNGER structure solution CNSSOLVE 0.9a BRUNGER refinement CNSSOLVE 0.9a 500 Bruker DMX VAL 1 n 1 VAL 1 A GLY 2 n 2 GLY 2 A CYS 3 n 3 CYS 3 A GLU 4 n 4 GLU 4 A GLU 5 n 5 GLU 5 A CYS 6 n 6 CYS 6 A PRO 7 n 7 PRO 7 A MET 8 n 8 MET 8 A HIS 9 n 9 HIS 9 A CYS 10 n 10 CYS 10 A LYS 11 n 11 LYS 11 A GLY 12 n 12 GLY 12 A LYS 13 n 13 LYS 13 A ASN 14 n 14 ASN 14 A ALA 15 n 15 ALA 15 A LYS 16 n 16 LYS 16 A PRO 17 n 17 PRO 17 A THR 18 n 18 THR 18 A CYS 19 n 19 CYS 19 A ASP 20 n 20 ASP 20 A ASP 21 n 21 ASP 21 A GLY 22 n 22 GLY 22 A VAL 23 n 23 VAL 23 A CYS 24 n 24 CYS 24 A ASN 25 n 25 ASN 25 A CYS 26 n 26 CYS 26 A ASN 27 n 27 ASN 27 A VAL 28 n 28 VAL 28 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ASP 20 A N ASP 20 A O VAL 23 A O VAL 23 1 A HIS 9 -58.49 -77.76 1 A LYS 13 -157.18 -41.38 1 A ASN 27 -128.28 -84.43 2 A CYS 10 -177.50 123.88 2 A ASN 27 -157.89 -85.43 3 A GLU 5 -142.37 29.63 3 A ASN 27 -147.25 -82.26 4 A HIS 9 -83.68 -75.19 4 A LYS 11 -174.34 115.62 4 A LYS 13 -157.32 -32.03 4 A ASN 27 -135.33 -86.17 5 A CYS 10 55.61 104.28 5 A LYS 13 -160.00 -42.04 5 A ASN 27 -125.66 -81.81 6 A LYS 13 -156.08 -40.87 6 A ASN 27 -138.74 -86.69 7 A ASN 14 -142.11 29.08 7 A ALA 15 178.48 131.05 7 A ASN 27 -132.90 -84.01 8 A HIS 9 -71.75 -77.72 8 A LYS 13 -160.21 -37.34 8 A ASN 27 -127.35 -83.08 9 A ASN 14 -140.43 29.21 9 A ALA 15 -177.65 129.75 9 A ASN 27 -127.18 -83.24 10 A HIS 9 -80.49 -75.36 10 A LYS 13 -155.18 -25.52 10 A ALA 15 -176.03 128.75 10 A ASN 27 -124.88 -82.16 11 A HIS 9 -76.11 -77.49 11 A LYS 13 -158.85 -41.23 11 A ASN 27 -121.72 -88.99 12 A CYS 10 56.78 -172.91 12 A LYS 13 -161.02 -34.57 13 A MET 8 -176.96 -40.61 13 A LYS 13 -153.65 -25.07 13 A ALA 15 -176.21 128.42 13 A ASN 27 -138.37 -82.02 14 A ASN 27 -143.50 -82.45 15 A HIS 9 -71.91 -79.13 15 A ASN 27 -149.30 -82.36 16 A MET 8 179.14 -37.76 16 A CYS 10 -170.57 -83.81 16 A LYS 11 59.11 115.43 16 A LYS 13 -162.70 -58.66 16 A ASN 27 -151.05 -86.59 17 A CYS 10 -150.25 88.37 17 A ASN 27 -140.90 -82.48 18 A LYS 13 -161.12 -30.67 18 A ALA 15 -175.51 128.83 18 A ASN 27 -125.27 -93.29 19 A CYS 10 82.41 89.66 19 A LYS 13 -160.67 -43.09 19 A ASN 27 -137.98 -87.77 20 A LYS 13 -162.50 -36.37 20 A ASN 27 -129.86 -79.64 21 A LYS 13 -163.14 -42.38 21 A ASN 27 -126.32 -90.08 22 A ASN 14 -141.28 28.90 22 A ALA 15 -179.63 130.10 22 A ASN 27 -120.64 -80.02 23 A LYS 13 -151.87 -26.13 23 A ASN 27 -121.42 -82.28 24 A LYS 13 77.78 -14.56 24 A ASN 27 -116.64 -81.22 25 A LYS 13 77.70 -14.54 25 A ASN 27 -147.45 -79.37 minimized average SOLUTION STRUCTURE OF BMP02, A NATURAL SCORPION TOXIN WHICH BLOCKS APAMIN-SENSITIVE CALCIUM-ACTIVATED POTASSIUM CHANNELS, 25 STRUCTURES 1 N N A GLU 5 A GLU 5 HELX_P A CYS 10 A CYS 10 1 1 6 disulf 2.030 A CYS 3 A SG CYS 3 1_555 A CYS 19 A SG CYS 19 1_555 disulf 2.030 A CYS 6 A SG CYS 6 1_555 A CYS 24 A SG CYS 24 1_555 disulf 2.031 A CYS 10 A SG CYS 10 1_555 A CYS 26 A SG CYS 26 1_555 TOXIN HELIX, SHEET, toxin SCP2_MESMA UNP 1 29 Q9NJP7 29 56 1DU9 1 28 Q9NJP7 A 1 1 28 2 anti-parallel A PRO 17 A PRO 17 A ASP 20 A ASP 20 A VAL 23 A VAL 23 A CYS 26 A CYS 26 1 P 1